Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76526 - 76550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamibarotene	Investigational	NFE2L2	4780	downregulated	tamibarotene results in decreased expression of NFE2L2 mRNA	2q31.2	A24376
Tamibarotene	Investigational	NFYB	4801	downregulated	tamibarotene results in decreased expression of NFYB mRNA	12q23.3	A24376
Tamibarotene	Investigational	NIPSNAP1	8508	upregulated	tamibarotene results in increased expression of NIPSNAP1 mRNA	22q12.2	A24376
Tamibarotene	Investigational	NKG7	4818	upregulated	tamibarotene results in increased expression of NKG7 mRNA	19q13.41	A24376
Tamibarotene	Investigational	NPC2	10577	upregulated	tamibarotene results in increased expression of NPC2 mRNA	14q24.3	A24376
Tamibarotene	Investigational	NPIPA1	9284	downregulated	tamibarotene results in decreased expression of NPIPA1 mRNA	16p13.11	A24376
Tamibarotene	Investigational	NR2F2	7026	downregulated	tamibarotene results in decreased expression of NR2F2 mRNA	15q26.2	A24376
Tamibarotene	Investigational	OAS2	4939	upregulated	tamibarotene results in increased expression of OAS2 mRNA	12q24.13	A24376
Tamibarotene	Investigational	OASL	8638	upregulated	tamibarotene results in increased expression of OASL mRNA	12q24.31	A24376
Tamibarotene	Investigational	OCLN	100506658	upregulated	tamibarotene results in increased expression of OCLN mRNA	5q13.2	A24380
Tamibarotene	Investigational	ODC1	4953	downregulated	tamibarotene results in decreased expression of ODC1 mRNA	2p25.1	A24376
Tamibarotene	Investigational	OGG1	4968	upregulated	tamibarotene results in increased expression of OGG1 mRNA	3p25.3	A24376
Tamibarotene	Investigational	OGT	8473	downregulated	tamibarotene results in decreased expression of OGT mRNA	Xq13.1	A24376
Tamibarotene	Investigational	ORC2	4999	downregulated	tamibarotene results in decreased expression of ORC2 mRNA	2q33.1	A24376
Tamibarotene	Investigational	P2RX5	5026	upregulated	tamibarotene results in increased expression of P2RX5 mRNA	17p13.2	A20516
Tamibarotene	Investigational	P2RY14	9934	upregulated	tamibarotene results in increased expression of P2RY14 mRNA	3q25.1	A24376
Tamibarotene	Investigational	PAK1	5058	upregulated	tamibarotene results in increased expression of PAK1 mRNA	11q13.5-q14.1	A24376
Tamibarotene	Investigational	PGD	5226	upregulated	tamibarotene results in increased expression of PGD mRNA	1p36.22	A24376
Tamibarotene	Investigational	PHYHIP	9796	downregulated	tamibarotene results in decreased expression of PHYHIP mRNA	8p21.3	A24376
Tamibarotene	Investigational	PIK3CD	5293	upregulated	tamibarotene results in increased expression of PIK3CD mRNA	1p36.22	A24376
Tamibarotene	Investigational	PIK3CG	5294	upregulated	tamibarotene results in increased expression of PIK3CG mRNA	7q22.3	A24378 A24376
Tamibarotene	Investigational	PIKFYVE	200576	downregulated	tamibarotene results in decreased expression of PIKFYVE mRNA	2q34	A24376
Tamibarotene	Investigational	PIM1	5292	upregulated	tamibarotene results in increased expression of PIM1 mRNA	6p21.2	A24376
Tamibarotene	Investigational	PKN1	5585	upregulated	tamibarotene results in increased expression of PKN1 mRNA	19p13.12	A24376
Tamibarotene	Investigational	PKP4	8502	downregulated	tamibarotene results in decreased expression of PKP4 mRNA	2q24.1	A24376

Displaying entries 76526 - 76550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability